Reaction
Blood Stem Cell Transplant Failure reporting signals
As of the last recalculation, Blood Stem Cell Transplant Failure appears in 213 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is IFOSFAMIDE (PRR 216.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ifosfamide | 39 | 216.9 | 217.3 |
| Fludarabine Phosphate | 61 | 212.0 | 212.4 |
| Melphalan | 35 | 179.7 | 180.0 |
| Busulfan | 25 | 175.8 | 176.1 |
| Melphalan Hydrochloride | 37 | 174.3 | 174.6 |
| Anti-Thymocyte Globulin (Rabbit) | 9 | 113.8 | 113.9 |
| Thiotepa | 8 | 85.0 | 85.1 |
| Cyclophosphamide Injection, Solution | 89 | 83.7 | 83.7 |
| Cyclophosphamide | 89 | 83.7 | 83.7 |
| Cyclophosphamide For Injection | 89 | 83.7 | 83.7 |
| Etoposide | 45 | 75.6 | 75.6 |
| Cytarabine | 35 | 67.9 | 68.0 |
| Filgrastim | 23 | 66.9 | 66.9 |
| Cisplatin | 40 | 61.4 | 61.4 |
| Bleomycin Sulfate | 5 | 48.4 | 48.4 |
| Brentuximab Vedotin | 4 | 38.8 | 38.9 |
| Blinatumomab | 3 | 28.5 | 28.5 |